anmelden
OMX Stockholm 30
3.210,41
PKT
+25,50
PKT
+0,80
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Stockholm 30-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 09.01.23 | AstraZeneca Neutral | UBS AG | |
| 06.01.23 | AstraZeneca Neutral | Credit Suisse Group | |
| 05.01.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 05.01.23 | Nordea Bank Abp Registered Equal Weight | Barclays Capital | |
| 05.01.23 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 04.01.23 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 04.01.23 | ABB (Asea Brown Boveri) Outperform | Bernstein Research | |
| 03.01.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 23.12.22 | AstraZeneca Overweight | Barclays Capital | |
| 20.12.22 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 16.12.22 | Hennes Mauritz (H M, H&M) Hold | Deutsche Bank AG | |
| 15.12.22 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
| 15.12.22 | Hennes Mauritz (H M, H&M) Hold | Jefferies & Company Inc. | |
| 15.12.22 | AstraZeneca Buy | Deutsche Bank AG | |
| 15.12.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 15.12.22 | Hennes Mauritz (H M, H&M) Neutral | UBS AG | |
| 15.12.22 | Hennes Mauritz (H M, H&M) Neutral | Goldman Sachs Group Inc. | |
| 14.12.22 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 08.12.22 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 06.12.22 | Nordea Bank Abp Registered Overweight | JP Morgan Chase & Co. | |
| 06.12.22 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 06.12.22 | Hennes Mauritz (H M, H&M) Underperform | Credit Suisse Group | |
| 05.12.22 | Volvo (B) Neutral | JP Morgan Chase & Co. | |
| 05.12.22 | ABB (Asea Brown Boveri) Outperform | Bernstein Research | |
| 02.12.22 | AstraZeneca Buy | Deutsche Bank AG | |
| 02.12.22 | Hennes Mauritz (H M, H&M) Neutral | Goldman Sachs Group Inc. | |
| 01.12.22 | Hennes Mauritz (H M, H&M) Overweight | Barclays Capital | |
| 28.11.22 | Hennes Mauritz (H M, H&M) Sell | Goldman Sachs Group Inc. | |
| 25.11.22 | Hennes Mauritz (H M, H&M) Hold | Jefferies & Company Inc. | |
| 22.11.22 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 21.11.22 | ABB (Asea Brown Boveri) Outperform | RBC Capital Markets | |
| 21.11.22 | Hennes Mauritz (H M, H&M) Sell | Goldman Sachs Group Inc. | |
| 18.11.22 | Nordea Bank Abp Registered Neutral | Credit Suisse Group | |
| 18.11.22 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
| 14.11.22 | AstraZeneca Overweight | Barclays Capital | |
| 11.11.22 | AstraZeneca Buy | Deutsche Bank AG | |
| 10.11.22 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 10.11.22 | AstraZeneca Neutral | UBS AG | |
| 10.11.22 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 10.11.22 | AstraZeneca Overweight | JP Morgan Chase & Co. |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.